Alexander Ulfelder - Johns Hopkins Development

06/16/2026

When is myasthenia gravis treatment working as well as it should?

For people living with MG, the answer is not always obvious. Symptoms can fluctuate, routines can quietly change, and patients may begin adjusting to limitations without realizing how much their condition is affecting daily life.

In a recent Everyday Health article, Ricardo Roda, MD, PhD, Director of the Johns Hopkins Myasthenia Gravis Center, discusses why changes in vision, speech, swallowing, fatigue, limb strength, breathing, or daily activity can be important signals to track.

At Johns Hopkins Medicine, our multispecialty approach brings together diagnostic testing, treatment therapies, rehabilitation, pulmonary medicine, infusion treatments, and clinical studies to support patients with myasthenia gravis and other neuromuscular disorders.

Read the Everyday Health article:
https://conta.cc/3PSoe2p

Learn more about myasthenia gravis from The Johns Hopkins Department of Neurology:
https://conta.cc/4fBEjDT

06/11/2026

For more than a century, ketogenic diet therapy has remained one of the most fascinating tools in epilepsy care.

Developed in the 1920s to mimic the metabolic effects of fasting, the ketogenic diet can be highly effective for some patients with drug-resistant epilepsy. Yet even after 105 years of clinical use, researchers are still working to understand exactly why it works.

In a recent Medscape Medical News feature, Eric Kossoff, MD, pediatric neurologist and director of the ketogenic diet program at Johns Hopkins, helped explain why. The diet appears to influence multiple overlapping systems, including brain energy metabolism, excitation and inhibition, and possibly even the gut microbiome.

That complexity is also why a simple “keto pill” has remained elusive. As Dr. Kossoff notes, the benefit likely comes from the interplay of many mechanisms rather than a single pathway.

The article is a reminder that some of medicine’s most durable therapies still hold unanswered questions, and that continued research may help make effective treatments more practical, personalized, and accessible for patients with epilepsy.

Read the full Medscape Medical News feature: https://conta.cc/4gdP2EJ

06/09/2026

June is Myasthenia Gravis Awareness Month.

For people living with myasthenia gravis, fatigue can shift throughout the day, especially after repeated muscle use, heat, stress, illness, or poor sleep.

In a recent Everyday Health article, Ricardo Roda, MD, PhD, Director of the Johns Hopkins Myasthenia Gravis Center and Associate Professor of Clinical Neurology, explains why these patterns matter and how patients can use them to have more informed conversations with their care team.

At Johns Hopkins, our multispecialty approach brings together diagnostic testing, treatment therapies, rehabilitation, pulmonary medicine, infusion treatments, and clinical studies to support patients with myasthenia gravis and other neuromuscular junction disorders.

Read the Everyday Health article featuring Dr. Roda:
https://conta.cc/4ujBaw5

Learn more about the Johns Hopkins Myasthenia Gravis Center:
https://conta.cc/4aFnwwi

05/28/2026

What if stroke treatment could be guided by a more precise view of the brain’s most vulnerable tissue?

Johns Hopkins researchers, led by Richard Leigh, M.D., are studying advanced imaging methods that may help clinicians better understand the “leaky core” of an ischemic stroke, an area where disruption of the blood-brain barrier may offer important clues about injury, treatment response, and recovery.

This work reflects a larger shift in stroke research: moving toward more precise ways to see what is happening in the brain, so treatment and recovery strategies can become more targeted over time.

For Johns Hopkins Neurology, it is another example of the stroke ecosystem at work: imaging, vascular neurology, acute care, recovery, prevention, and research moving together.

🔗Read more:
https://www.hopkinsmedicine.org/news/newsroom/news-releases/2026/05/advanced-imaging-provides-precision-lens-for-treating-stroke

05/21/2026

May is National Stroke Awareness Month, a time to recognize both the urgency of stroke care and the research needed to improve outcomes for patients in the future.

At Johns Hopkins, the stroke mission brings together two deeply connected efforts.

The Johns Hopkins Hospital Comprehensive Stroke Center provides specialized care for patients experiencing stroke, from urgent diagnosis and treatment through recovery, rehabilitation, and long-term prevention.

The Sheikh Khalifa Stroke Institute serves as a translational research and innovation engine, drawing on Johns Hopkins’ leadership in stroke diagnosis, treatment, rehabilitation, biomedical research, technology, prevention, and public health to help shape the future of stroke care.

Together, they represent a connected stroke ecosystem: comprehensive care for patients today, and research that advances better approaches for tomorrow.

For alumni, physicians, and clinical colleagues caring for patients with complex stroke needs, Johns Hopkins Neurology remains a trusted resource for specialized expertise, multidisciplinary care, and research-informed treatment.

Learn more about the Sheikh Khalifa Stroke Institute and Johns Hopkins’ work to transform stroke care in the video below:
https://youtu.be/8RRqq8O8iKU

At Johns Hopkins, the Sheikh Khalifa Stroke Institute is preventing...